Location History:
- Kingston, CA (2002 - 2010)
- Battersea, CA (2012)
Company Filing History:
Years Active: 2002-2012
Title: The Innovative Contributions of Charles H. Graham
Introduction
Charles H. Graham is a notable inventor based in Kingston, Canada, recognized for his significant contributions to cancer treatment through innovative formulations and methods. With a total of four patents to his name, Graham has made strides in the field of medical research, particularly in the use of nitric oxide mimetics.
Latest Patents
Graham's latest patents focus on formulations and methods of using nitric oxide mimetics in cancer treatment. One of his inventions relates to methods for inhibiting, treating, and preventing malignant cell phenotypes, cells, tumors, and diseases. The administration of nitric oxide mimetics, even in low doses, is sufficient to enhance, restore, or maintain nitric oxide-mediated signaling in cells. This innovation aims to inhibit or prevent malignant cell phenotypes, making it particularly useful in treating and preventing cancer in animals.
Career Highlights
Throughout his career, Graham has worked with esteemed institutions such as Queen's University at Kingston and Cellegy Pharmaceuticals Inc. His work has been pivotal in advancing the understanding and treatment of cancer, showcasing his dedication to improving health outcomes.
Collaborations
Graham has collaborated with notable colleagues, including Michael A. Adams and Jeremy P. W. Heaton. These partnerships have contributed to the development of his innovative ideas and research.
Conclusion
Charles H. Graham's work exemplifies the impact of innovation in the medical field, particularly in cancer treatment. His patents and collaborations highlight his commitment to advancing healthcare through scientific research and development.